NCT01948401View on ClinicalTrials.gov

A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Asthma
Interventions
DRUG

LABA

long-acting beta-agonist treatment

DRUG

corticosteroids

chronic treatment with oral corticosteroids, high dose inhaled corticosteroids

DRUG

prednisolone

additional 0.5 mg/kg orally for 7 days

Trial Locations (11)

BT9 7AB

Belfast

B9 5SS

Birmingham

G12 0XH

Glasgow

G21 3UW

Glasgow

SO16 6YD

Hampshire

LE3 9QP

Leicester

EC1A 7BE

London

SW3 6NP

London

M23 9LT

Manchester

NE7 7DN

Newcastle upon Tyne

NG5 1PB

Nottingham

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01948401 - A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent Asthma | Biotech Hunter | Biotech Hunter